Personalizing the MDD Treatment Journey: Putting Patient-Centered Care Into Practice

CME Activities

Can You Provide Individualized Care to These Patients With Depression? Virtual Case Challenges

Medscape Education Psychiatry & Mental Health, December 2022

Can you recognize residual symptoms of depression in your patients? Sharpen your skills and expand your toolbox to individualize treatment

1.00 CME

1.00 ABIM MOC

1.00 CE

1.00 CE
An Enduring Program on 360-Degree Care in MDD: The Role of Primary Care Teams in Optimizing Patient Outcomes

Medscape Education Family Medicine, October 2022

Could your primary care team lead the way in optimizing patient outcomes in major depressive disorder (MDD) care?

0.75 CME

0.75 ABIM MOC

0.75 CE
Clinical Connect: Addressing Residual Symptoms and Preventing Relapse in Major Depressive Disorder

Medscape Education Family Medicine, September 2022

Are you up to date on the latest in treatment for major depressive disorder (MDD)?

0.50 CME

0.50 ABIM MOC

0.50 CE

0.50 CE
Frontline Challenges in Major Depressive Disorder – A Guide for the Primary Care Team 

Medscape Psychiatry, September 2022

Learn from the experts how to recognize and manage functional impairments and residual symptoms of major depressive disorder (MDD).

0.75 CME

0.75 ABIM MOC

0.75 CE

0.75 CE

Resources

Clinical Articles

Patient Education

Personalizing Your Depression Treatment Journey

Steering Committee

Rakesh Jain, MD, MPH

Steering Committee Chair

Has disclosed the following relevant financial relationships:

Served as an advisor or consultant for: Abbvie, Allergan, Acadia, Adamas, Alfasignma, Cingulate Therapeutics, Eisai, Evidera, Impel, Janssen, Lilly, Lundbeck, Merck, Neos Therapeutics, Neurocrine Biosciences, Osmotica, Otsuka, Pamlab, Pfizer, Sage Therapeutics, Shire, Sunovion, Supernus, Takeda, Teva

Served as a speaker or a member of a speakers bureau for: Abbvie (Allergan), Alkermes, Corium, Indivior, Intra-Cellular Therapies, Ironshore Pharmaceuticals, Janssen, Lilly, Lundbeck, Merck, Neos Therapeutics, Neurocrine, Otsuka, Pamlab, Pfizer, Shire, Sunovion, Takeda, Teva, Tris Pharmaceuticals

Received grants for clinical research from: Abbvie (Allergan), Lilly, Lundbeck, Otsuka, Pfizer, Shire, Takeda

Denise Vanacore, ANP-BC, CRNP, PhD, PMHNP-BC

Steering Committee Chair

Has disclosed the following relevant financial relationships:

Served as a speaker or a member of a speakers bureau for: Abbvie

Anita H. Clayton, MD

Steering Committee Member

Has disclosed the following relevant financial relationships:

Served as an advisor or consultant for: Acadia, Alkermes, Allergan, AMAG Pharmaceuticals, Astellas, Fabre-Kramer, Janssen Research & Development, MindCure, Ovoca Bio, Praxis Precision Medicines, PureTech Health, S1 Biopharma, Sage Therapeutics, Takeda/Lundbeck, Vella Bioscience, WCG MedAvante-Prophase

Received grants for clinical research from: Dare Bioscience, Janssen, Relmada Therapeutics, Sage Therapeutics, Praxis Precision Medicines

Owns stock, stock options, or bonds from: Euthymics, Mediflix, S1 Biopharma

Larry Culpepper, MD, MPH

Steering Committee Member

Has disclosed the following relevant financial relationships:

Served as an advisor or consultant for: AbbVie Pharmaceuticals, Acadia Pharmaceuticals, Allergan Pharmaceuticals, Eisai Pharmaceuticals, Supernus Pharmaceuticals, Inc., Takeda Pharmaceuticals

Owns stock, stock options, or bonds from: M-3 Information

Sarah T Melton, PharmD, BCPP, BCACP, CGP, FASCP

Steering Committee Member

Disclosure: Sarah T Melton, PharmD, BCPP, BCACP, CGP, FASCP, has disclosed no relevant financial relationships.

Sagar Parikh, MD

Steering Committee Member

Has disclosed the following relevant financial relationships:

Served as an advisor or consultant for: Takeda, Lundbeck, Otsuka, Sage, Aifred, Mensante, Assurex (Myriad)

Received grants for clinical research from: Takeda, Aifred, Sage, Assurex

Owns stock, stock options, or bonds from: Mensante